Filing Details

Accession Number:
0000899243-19-003661
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-14 17:29:12
Reporting Period:
2019-02-12
Accepted Time:
2019-02-14 17:29:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1629137 Global Blood Therapeutics Inc. GBT Pharmaceutical Preparations (2834) 274825712
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730866 Ann Lesley Calhoun C/O Global Blood Therapeutics, Inc.
171 Oyster Point Blvd., Suite 300
South San Francisco CA 94080
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-31 354 $36.68 1,386 No 5 A Direct
Common Stock Disposition 2019-02-12 354 $50.45 1,032 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).